Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000–2015
Hatim Sati(World Health Organization), Marcos Espinal(World Health Organization), Pilar Ramón-Pardo(World Health Organization Regional Office for the Americas), Antonio Sanhueza(World Health Organization Regional Office for the Americas), Marcelo Galas(World Health Organization Regional Office for the Americas), Nienke Bruinsma(World Health Organization Regional Office for the Americas), Jenny Hsieh(World Health Organization Regional Office for the Americas)
Cited by 25
Related Papers
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
|Science|2002|315
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance
|Bulletin of the World Health Organization|2023|276
Worldwide Incidence of Multidrug‐Resistant Tuberculosis
|The Journal of Infectious Diseases|2002|270
Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings
|International Journal of Infectious Diseases|2021|256